Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Ressources
Guidelines | 2023
Clinical guidance, Substitution/OAT
Guide | 2023
les guides de pratique clinique, à propos des prescripteurs, à propos des pharmaciens, la surdose, la mortalité, la politique / le cadre de réglementation
Guidelines | 2022
Overdose, Clinical guidance
This study analysed the perspectives from a broad range of service providers, whose work was impacted or related to the RMG, to elucidate a nuanced narrative regarding the perceived facilitators an
Thesis | 2023
About prescribers, Safer supply, Barriers and enablers, Clinical guidance
We conducted a policy scan of UDS guidelines, examining the published clinical practice guidelines for each Canadian province and extracting all relevant data in March 2017.
Guidelines | 2018
Clinical guidance, Substitution/OAT, About prescribers
We aimed to examine comprehensively the evidence for agreement between self-reported and biologically measured illicit drug use across all major illicit drug classes, biological indicators, populat
Lit review | 2023
About PWUD, Illegal drugs, Clinical guidance
Guide | 2023
les guides de pratique clinique, le traitement de substitution/TAO
Guide | 2023
les guides de pratique clinique, à propos des prescripteurs, le traitement de substitution/TAO
We performed a global survey of existing deprescribing (tapering) services to identify common practices and inform service development.
Original research | 2023
Clinical guidance, About prescribers, Transitions in care/treatment
Guidelines | 2023
Clinical guidance, Harm reduction, Safer supply, About prescribers
This study explored the use of tiered mentoring opportunities within an ECHO® model to expand treatment capacity and develop a statewide network of medications for OUD (MOUD) expertise.
Original research | 2023
About prescribers, Clinical guidance, Hesitancy of prescribers
Manuel | 2023
le stigmate social, à propos des prescripteurs, les services sociaux, la politique / le cadre de réglementation, les obstacles et les facilitateurs, les guides de pratique clinique
Guide or handbook | 2023
Stigma, About prescribers, Social services, Policy/Regulatory, Barriers and enablers, Clinical guidance
Webpage | 2023
Clinical guidance, Harm reduction, About prescribers
Collecting in-person UDS may not always be feasible, contributing to the need to understand factors that influence the validity of self-reported substance use.
Original research | 2023
About PWUD, Clinical guidance
Guidelines | 2023
Clinical guidance, About prescribers, Substitution/OAT
Guide or handbook | 2022
Policy/Regulatory, Clinical guidance
Case study | 2022
Injecting drugs, Hospitals, Clinical guidance, Harm reduction
